Sudarshan Chemical Industries Reaffirmed at CRISIL A1+

Rating Action: CRISIL A1+ reaffirmed for Rs 50 crore commercial paper programme.
Financial Profile: Adjusted net worth of Rs 2,506 crore with strong liquidity surplus.

Reader Takeaway: Strong liquidity supports debt servicing, while the upcoming sale of VP4 Frankfurt GmbH signals future deleveraging.

What just happened

CRISIL Ratings has reaffirmed the 'CRISIL A1+' credit rating for the commercial paper programme of Sudarshan Chemical Industries Ltd (SCIL). The rating reflects the company's ability to maintain high liquidity and stable debt-servicing capability.

Why this matters

Maintaining a top-tier credit rating is essential for companies accessing short-term debt markets. For shareholders, this signals institutional confidence in the company’s near-term solvency. The rating agency highlighted a significant liquid surplus of Rs 1,397 crore as of March 2026, providing a buffer for ongoing operations and capital expenditure.

The backstory

SCIL is currently focused on optimizing its balance sheet. A critical development is the proposed divestment of its subsidiary, VP4 Frankfurt GmbH, to Celanese US Holdings for approximately Rs 840 crore. The proceeds from this sale are earmarked for the prepayment of acquisition-related debt, which should improve the company's gearing ratio of 0.99 times.

Financial Snapshot

In Q1 fiscal 2027, the company reported revenue of Rs 2,642 crore, marking a 5.4% year-on-year increase. Notably, the EBITDA margin improved significantly to 10.1%, up from 6.6% in the same period last year, driven by successful cost-optimization efforts.

Risks to watch

While liquidity remains strong, investors should monitor the successful completion of the VP4 Frankfurt GmbH divestment. Delays in executing this sale or higher-than-expected interest costs could pressure return metrics in the medium term.

What to track next

The primary monitorable for investors is the closure of the VP4 transaction and the subsequent reduction in net debt, which remains a core pillar of the company's deleveraging strategy.